Esketamine shows favorable efficacy for postoperative analgesia and is associated with a lower risk of postpartum depression, but the result is unstable and may increase dizziness in pregnant women over 30.
Abstract
As a therapy for postoperative analgesia, esketamine shows relatively favorable efficacy in pain control and is associated with a lower risk of postpartum depression. However, this result is unstable. Furthermore, esketamine may increase the risk of dizziness in pregnant women aged over 30 years. Since all the experiments in this study are conducted in China, there are certain regional limitations.